About the Event
The Advanced Therapies Congress brings together speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, regulators.
Robert Leydon, Group Leader, AAV, OXGENE, will be presenting “Transforming Scalable AAV Manufacture using TESSA® Technology”. Our team will also be exhibiting and would be happy to meet!